Form 4: TriSalus Life Sciences Executive Jennifer Stevens Reports Acquisition of 14,481 Shares of Common Stock
SEC Form 4 Filing
Jennifer Stevens, Chief Regulatory Officer of TriSalus Life Sciences, reports the acquisition of 14,481 shares of common stock through a restricted stock unit award.
Summary
- On February 18, 2025, Jennifer Stevens, the Chief Regulatory Officer of TriSalus Life Sciences, acquired 14,481 shares of common stock.
- This acquisition was through a grant of restricted stock units (RSU Award).
- 12.5% of the shares will vest on the grant date of February 18, 2025.
- 25% of the shares will vest on each of May 15, 2025, August 15, 2025, and November 14, 2025.
- The remaining shares will vest on February 13, 2026, contingent upon continued service with the Issuer.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices and aligns management interests with shareholders.
Positives
- The acquisition of shares by a key executive signals confidence in the company's future.
Future Outlook
The vesting schedule of the restricted stock units incentivizes continued service of the Reporting Person with the Issuer.
Industry Context
Stock grants are a common form of executive compensation in the life sciences industry, aligning management's interests with those of shareholders.
Stakeholder Impact
- The stock grant aligns the executive's interests with those of shareholders, potentially driving long-term value creation.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date of transaction and grant date of restricted stock units; 12.5% of shares vest. |
| 05/15/2025 | 25% of shares subject to RSU Award vest. |
| 08/15/2025 | 25% of shares subject to RSU Award vest. |
| 11/14/2025 | 25% of shares subject to RSU Award vest. |
| 02/13/2026 | Remaining shares subject to RSU Award vest. |
| 02/19/2025 | Date of signature on the Form 4 filing. |
Keywords
TriSalus Life Sciences, Jennifer Stevens, restricted stock units, RSU, Form 4, beneficial ownership, TLSI, executive compensation, stock award
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.